Add like
Add dislike
Add to saved papers

Excited-State Processes of Cyclometalated Platinum(II) Charge-Transfer Dimers Bridged by Hydroxypyridines.

Inorganic Chemistry 2018 Februrary 6
A series of four anti-disposed dinuclear platinum(II) complexes featuring metal-metal-to-ligand charge-transfer (MMLCT) excited states, bridged by either 2-hydroxy-6-methylpyridine or 2-hydroxy-6-phenylpyridine and cyclometalated with 7,8-benzoquinoline or 2-phenylpyridine, are presented. The 2-hydroxypyridine bridging ligands control intramolecular d8 -d8 metal-metal σ interactions, affecting the frontier orbitals' electronic structure, resulting in marked changes to the ground- and excited-state properties of these complexes. Three of these molecules possess reversible one-electron oxidations in cyclic voltammetry experiments as a result of strong intramolecular metallophilic interactions. In this series of molecules, X-ray crystallography revealed Pt-Pt distances ranging between 2.815 and 2.878 Å; the former represents the shortest reported metal-metal distance for platinum(II) dimers possessing low-energy MMLCT transitions. All four molecules reported here display visible absorption bands beyond 500 nm and feature MMLCT-based red photoluminescence (PL) above 700 nm at room temperature with high PL quantum yields (up to 4%) and long excited-state lifetimes (up to 341 ns). The latter were recorded using both transient PL and transient absorption experiments that self-consistently yielded quantitatively identical excited-state lifetimes. The energy-gap law was successfully applied to this series of chromophores, documenting this behavior for the first time in molecules possessing MMLCT excited states. The combined data illustrate that entirely new classes of MMLCT chromophores can be envisioned using bridging pyridyl hydroxides in cooperation with various C^N cyclometalates to achieve photophysical properties suitable for excited-state electron- and energy-transfer chemistry.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app